SynthesisFrontiers in immunology2026

Efficacy of PD-1/PD-L1 plus CTLA-4 inhibitors in advanced/metastatic NSCLC: a meta-analysis based on RCTs.

Tianfu Dai et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.